Skip to the page

Data / Medical devices / United States / BioReference Health, LLC

BioReference Health, LLC: FDA-registered device maker in Elmwood Park, NJ, United States, 1 PMA approval

BioReference Health, LLC is registered with the FDA (registration 3003652672) in Elmwood Park, NJ, United States. It lists 1 device type. The FDA files 1 PMA approval under its listings, the newest dated December 7, 2021. 2 recall events name it as the recalling firm. Registered through 2026. FDA data exported November 2, 2026.

SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.

FDA registration number
3003652672
Address
481 Edward H. Ross Drive, Elmwood Park, NJ, United States, 07407
Owner or operator
OPKO Health, Inc. (10059750)
Roles
Complaint file establishment, Manufacturer
First device listed
January 13, 2022
Registered through
2026
Brand names listed
4Kscore Test

Devices it lists

DeviceProduct codeClassRoleSource
Multi-Analyte Test System With Algorithmic Analysis For Detection Of Prostate CancerQRF3Complaint file establishment, Manufactureraccessdata.fda.gov

PMA approvals

Premarket approvals this establishment lists, with the supplements the FDA has decided since.

ApprovedPMA numberDeviceProduct codeSupplementsLatest decisionSource
December 7, 2021P1900224Kscore TestQRF3July 25, 2025accessdata.fda.gov

Recalls

Recall events where this establishment is the recalling firm, matched on its FEI.

InitiatedEventClassStatusProductReasonSource
October 31, 202393050Class IIOngoingThe 4Kscore Test, an in vitro serum or plasma test that combines the results of four immunoassays (Roche Elecsys total PSA (prostate specific antigen), Roche Elecsys free PSA, intact PSA, and human kallikrein 2) into a sMathematical modeling of the 4Kscore with and without DRE information was recently performed on over 3,000 specimens. DRE information is a required component of The 4Kscore Test.accessdata.fda.gov
November 18, 202292205Class IIOngoingThe 4Kscore Test is an in vitro serum or plasma test that combines the results of four immunoassays (Roche Elecsys total PSA (prostate specific antigen), Roche Elecsys free PSA, intact PSA, and human kallikrein 2) into aSPM software anomalies that may lead to the generation of erroneous 4Kscore Test resultsaccessdata.fda.gov

Updated July 25, 2025. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.